Member Info for ConsDoms

Baran! Im starting to like you!

I wouldn't Davie b, absolutely not. And Ive definitely bought more than I should. The next few months look like they could define HEMO now. If it doesn't become the multi million mcap I expect then that is totally on me. If folk didn't believe in the science why did they invest here - the trials will prove the science or not.

It was over £90m when FDA approved (during the day)

Tightly coiled spring

14 weeks since P2 treated though.

we pray P3 is is well enough to receive the treatment any day

Shuggy - they've just announced stopping $500m of mRNA funding

Yes, but pkenny inferring HEMO are a cheap target (perhaps I read wrong)

What if holders and Vlad dont accept what they consider to be a low ball offer?

You insulted Haywain out of nowhere boom, you just seem very angry with him. why not offer a technical alternative to his commentary on the CAR T rather than getting angry and ranting

You still haven't answered the question boom ie which one of haywain technical points do you contest?

and you lord it over this site about hurling insults but it is unclear why you started hurling insults at Haywain in the first instance - did you initially believe his view - but now you have spent all your housekeeping you have done a u turn? (so spew your hate towards him)

If HEMO don’t secure an arrangement for in excess of 200m this year I would perhaps consider your point. But at the moment they are still gathering data. So your view is pure speculation. As is mine and anybody else’s.

Thank you Socialist

Interesting Socialist. Thanks. What price will they be paying- £1.80?

Estimate the efficacy of HG-CT-1 cells as defined by clinical response according to established criteria for AML.

Proportion of subjects with response, according to ELN 2022 criteria. {Dohner et al., 2022 #29518}. To demonstrate the anti-AML activity of HG-CT-1.

Day 14, Day 28, Month 3, Month 6 and Month 12

Determine the safety of HG-CT-1 cells based on the proportion of subjects infused with HG-CT-1 who experience a DLT.

Occurrence of dose-limiting toxicities related to HG-CT-1. First-in-human study with unknown safety of infusion of HG-CT-1.

From the time of HG-CT-1 infusion until Day 28

Only 110m mcap Mick

Will Grok know why no formal confirmation of second patient infusion?

Nice post hfh. some of us LTHs a little beat though. formal confirmation of efficacy and second patient infusion would do wonders

Let’s face it though MrI. Us holders would feel slightly easier once infusion formally confirmed

Hi Andy, I thought it was very relevant but I wouldn't dare dicate to anybody on here whether it was relevant or not. $425m initial payment after just one patient / within 4 months of treatment commencing. (Sorry I didn't post it bang on the day it was reported)